What is Self Injection Device?
Patients who require regular doses of medicine and hormones for long-term management of illnesses and diseases such as diabetes and rheumatoid arthritis benefit from self-injection devices. Self-injection Devices are available in both reusable and disposable versions. Self-injection Devices have benefits such as less hospital visits, ease of use, and low cost. Patients with chronic conditions can take control of their treatment schedule and treatment setting with self-injection devices, giving them more independence and freedom in their social, personal, and professional lives. Self-injection may also provide psychological advantages over professional administration, such as greater self-esteem. Removing the need for regular injections at a clinic or hospital also saves money for both the patient and the healthcare system. This economic gain has been the primary driver of market growth.
|Unit||Value (USD Million)|
|Key Companies Profiled||Becton (United States), Sensile Medical AG. (Switzerland), Owen Mumford Ltd. (United Kingdom), SHL Group (Switzerland), Wilhelm Haselmeier GmbH & Co. KG. (Germany), Dickinson and Company (United States), West Pharmaceutical Services (United States), Gerresheimer AG (Germany), Insulet Corporation (United States) and Ypsomed AG (Switzerland)|
The market study is broken down by Type (Reusable and Disposable), by Application (Cancer, Auto-Immune Diseases, Hormonal Disorders, Pain Management and Others) and major geographies with country level break-up.
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Self Injection Device market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Becton (United States), Sensile Medical AG. (Switzerland), Owen Mumford Ltd. (United Kingdom), SHL Group (Switzerland), Wilhelm Haselmeier GmbH & Co. KG. (Germany), Dickinson and Company (United States), West Pharmaceutical Services (United States), Gerresheimer AG (Germany), Insulet Corporation (United States) and Ypsomed AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Antares Pharma, Inc. (United States) and Consort Medical plc. (United Kingdom).
AdvanceMarketAnalytics has segmented the market of Global Self Injection Device market by Type, Application and Region.
On the basis of geography, the market of Self Injection Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Product Type, the sub-segment i.e. Pen Injectors will boost the Self Injection Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In December 2021 - NuGen Medical Devices Company announce the launch of a needle-free injection system in Canada. They got approval from Health Canada for its needle-free injection system and accessories, also known as InsuJet.
- Technological Advancements In Self-Injection Devices
- Growing Demand For Auto-Injectors And Wearable Injectors
- High Prevalence And Incidence Rates Of Chronic Disorders
- Increase In Demand For Biosimilar Drugs
- Increasing Population Suffering From Autoimmune Disorders Across The Globe
- Worldwide Increase In Diabetes And The Growing Pressure On Health Care Costs
- Strict Regulation For Patent Approval
- Lack Of Awareness Among The People In Underdeveloped And Developing Countries
Key Target AudienceSelf Injection Device Manufacturers, Self Injection Device Distributors/Traders/Wholesalers, Self Injection Device Subcomponent Manufacturers, Industry Association and Downstream Vendors
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.